Humana Inc. (HUM) Stock Forecast
HUM analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.04 / 5 from 26 analysts
- Price target
- $465.12 average of analyst targets
- Upside to target
- +12.6% from the latest close
- Next earnings
- November 6, 2026 EPS estimate $-1.03
- 52-week range
- $163.67 – $433.50
HUM analyst ratings
26 analystsNumber of analysts at each rating.
HUM price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HUM earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$1.00 | −$1.16 | −$0.60 | $3.24 | −131.0% | 23 |
| Current fiscal year (2026) | $9.16 | $8.45 | $10.55 | $17.14 | −46.6% | 26 |
| Next fiscal year (2027) | $17.09 | $10.39 | $20.75 | $9.16 | +86.6% | 26 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HUM revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $40.89B | $40.43B | $41.44B | +25.2% | 17 |
| Current fiscal year (2026) | $162.74B | $161.58B | $164.99B | +25.5% | 21 |
| Next fiscal year (2027) | $168.69B | $157.19B | $177.62B | +3.6% | 21 |
HUM EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HUM revenue: reported and forecast
HUM EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.14 | −$1.02 | −$0.94 | −$1.00 | −$1.00 | +607.5% | 0 up · 4 down |
| Current fiscal year (2026) | $8.96 | $9.15 | $9.15 | $9.16 | $9.16 | +2.3% | 5 up · 1 down |
| Next fiscal year (2027) | $16.03 | $16.57 | $16.57 | $16.59 | $17.09 | +6.6% | 6 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HUM earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HUM beat in 10 of 12.
What analysts expect from HUM
26 analysts cover Humana; their consensus rating is buy (4.04 on a 1–5 scale, where 5 is a strong buy). The average price target is $465.12, 12.6% above the latest close of $413.16. Analysts expect earnings of $9.16 per share for 2026, −46.6% from a year earlier. For 2027 the average estimate is $17.09 per share on revenue of $168.7 billion. Humana beat the EPS estimate in 10 of the last 12 quarters.
Related: HUM income statement, HUM key metrics, HUM chart. See the HUM stock overview for the latest quote and news.
HUM forecast FAQ
What is Humana's price target?
The average analyst price target for Humana is $465.12, 12.6% above the latest close of $413.16.
Is Humana a buy, hold or sell?
Of 26 analysts covering Humana, 13 rate it a strong buy, 3 a buy, 9 a hold, 0 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Humana's EPS forecast?
Analysts forecast $9.16 per share for 2026 (range $8.45 to $10.55); for 2027 the estimate is $17.09.
What is Humana's revenue forecast?
The average revenue estimate for 2026 is $162.7 billion, growth of 25.5%; for 2027 it is $168.7 billion.
When does Humana report earnings?
Humana is expected to report results for the quarter ending September 30, 2026 on November 6, 2026 before the market opens; the EPS estimate is $-1.03.
Does Humana usually beat earnings estimates?
Humana reported EPS at or above the analyst estimate in 10 of the last 12 quarters.